Financial Times reports on steps by major AI labs to limit misuse risks.
The Financial Times reports that Anthropic, OpenAI and Google DeepMind are increasing work on biological risk testing, access controls and other safeguards. These steps target misuse of advanced AI systems. The companies expect the systems to speed drug discovery, aid disease research and help prevent pandemics. The linked article notes concern from executives and biosecurity experts that future models could help users create novel viruses or bioweapons.
32.6K
1 post, first seen 4d ago
Financial Times reports on steps by major AI labs to limit misuse risks.
The Financial Times reports that Anthropic, OpenAI and Google DeepMind are increasing work on biological risk testing, access controls and other safeguards. These steps target misuse of advanced AI systems. The companies expect the systems to speed drug discovery, aid disease research and help prevent pandemics. The linked article notes concern from executives and biosecurity experts that future models could help users create novel viruses or bioweapons.
Financial Times@FTAnthropic, OpenAI and Google DeepMind are stepping up work on biological risk testing, access controls and other safeguards to limit misuse of advanced AI systems that they hope will speed up drug discovery, aid disease research and prevent pandemics https://ft.trib.al/x4ZFwlq
Financial Times@FTAnthropic, OpenAI and Google DeepMind are stepping up work on biological risk testing, access controls and other safeguards to limit misuse of advanced AI systems that they hope will speed up drug discovery, aid disease research and prevent pandemics https://ft.trib.al/x4ZFwlq
